Pharmaceutical Sales 2004

The following is a list of the top 200 pharmaceutical drugs by retail sales in 2004, listed by U.S. sales value and brand name.
New: Quarterly Top 100 prescription sales data now available, from Q1 2011 more....

Top 200 Drugs for 2004 by Sales

View data for: 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012

Rank Drug Current Manufacturer Total Sales ($000) % Change 2003
1 Lipitor Pfizer Inc 5,959,955 10.9%
2 Prevacid Takeda Pharmaceuticals U.S.A., Inc 3,197,890 -4.8%
3 Zocor Merck & Co., Inc. 3,150,892 2.8%
4 Nexium AstraZeneca Pharmaceuticals, LP 2,963,518 19.0%
5 Zoloft Pfizer Inc 2,622,801 6.6%
6 Advair Diskus GlaxoSmithKline 2,323,170 22.7%
7 Effexor XR Pfizer Inc 2,281,014 19.4%
8 Plavix Bristol-Myers Squibb Company 2,169,479 30.4%
9 Celebrex Pfizer Inc 2,114,734 6.0%
10 Neurontin Pfizer Inc 2,000,077 3.1%
11 Protonix Wyeth 1,910,067 26.8%
12 Norvasc Pfizer Inc 1,883,014 9.8%
13 Zyprexa Eli Lilly and Company 1,881,354 -8.8%
14 Singulair Merck & Co., Inc. 1,849,025 24.2%
15 Ambien Pfizer Inc 1,719,253 18.3%
16 OxyContin Purdue Pharma LP 1,700,737 0.0%
17 Lexapro Forest Pharmaceuticals, Inc 1,551,230 69.2%
18 Pravachol Bristol-Myers Squibb Company 1,522,955 -3.7%
19 Fosamax Merck & Co., Inc. 1,463,390 6.8%
20 Risperdal Janssen Pharmaceuticals, Inc 1,436,891 1.9%
21 Actos Takeda Pharmaceuticals U.S.A., Inc 1,388,002 12.5%
22 Seroquel AstraZeneca Pharmaceuticals, LP 1,378,038 30.4%
23 Allegra Sanofi (formerly Sanofi Aventis) 1,260,443 -6.6%
24 Duragesic Johnson & Johnson 1,208,391 22.4%
25 Aciphex Eisai Corporation 1,139,155 8.8%
26 Levaquin Janssen Pharmaceuticals, Inc 1,128,679 8.0%
27 Vioxx Merck & Co., Inc. 1,088,453 -28.0%
28 Toprol XL AstraZeneca Pharmaceuticals, LP 1,075,725 22.0%
29 Zithromax Z-Pak Pfizer Inc 1,070,535 -4.2%
30 Avandia GlaxoSmithKline 1,054,786 9.0%
31 Bextra Pfizer Inc 1,053,079 28.2%
32 Topamax Janssen Pharmaceuticals, Inc 1,052,107 24.0%
33 Zyrtec Johnson & Johnson 1,015,113 -2.1%
34 Lotrel Novartis Corporation 970,827 20.4%
35 Enbrel Amgen Inc. 955,266 22.5%
36 Wellbutrin XL Valeant Pharmaceuticals International 948,683 915.9%
37 Flonase GlaxoSmithKline 930,267 11.3%
38 Viagra Pfizer Inc 906,580 -19.2%
39 Synthroid Abbott Laboratories 873,282 -1.1%
40 Celexa Forest Pharmaceuticals, Inc 856,665 -29.5%
41 Paxil CR Apotex Corp 824,433 15.4%
42 Valtrex GlaxoSmithKline 801,721 31.8%
43 Lamictal GlaxoSmithKline 780,614 44.0%
44 Imitrex Oral GlaxoSmithKline 780,613 1.9%
45 Adderall XR Shire US Inc 777,879 38.1%
46 Concerta Johnson & Johnson 764,317 24.3%
47 Abilify Bristol-Myers Squibb Company 747,400 115.1%
48 Diovan Novartis Corporation 723,821 21.2%
49 Premarin Tabs Wyeth 702,872 -18.0%
50 Zetia Merck & Co., Inc. 687,673 104.8%
51 Tricor Abbott Laboratories 684,984 28.8%
52 Actonel Actavis (acquired Watson & Warner Chilcott) 682,554 47.1%
53 Altace King Pharmaceuticals, Inc. (now part of Pfizer - October 2010) 659,710 11.5%
54 Strattera Eli Lilly and Company 646,238 87.3%
55 Diovan HCT Novartis Corporation 627,878 29.8%
56 Coreg GlaxoSmithKline 626,189 36.4%
57 Lamisil Oral Novartis Corporation 603,003 11.6%
58 Depakote Abbott Laboratories 588,935 -1.6%
59 Aricept Eisai Corporation 584,302 18.5%
60 Cozaar Merck & Co., Inc. 558,232 7.8%
61 Evista Eli Lilly and Company 544,966 -1.2%
62 Flomax Boehringer Ingelheim Pharmaceuticals, Inc 541,800 4.9%
63 Lantus Sanofi (formerly Sanofi Aventis) 537,299 54.2%
64 Wellbutrin SR GlaxoSmithKline 529,332 -66.8%
65 Detrol LA Pfizer Inc 507,354 14.8%
66 Crestor AstraZeneca Pharmaceuticals, LP 503,011 >999
67 Nasonex Merck & Co., Inc. 498,730 1.5%
68 Clarinex Merck & Co., Inc. 498,199 -18.9%
69 Zofran GlaxoSmithKline 495,657 15.9%
70 Accupril Pfizer Inc 457,876 -10.7%
71 Flovent GlaxoSmithKline 456,600 -8.8%
72 Combivent Boehringer Ingelheim Pharmaceuticals, Inc 454,028 15.5%
73 Humalog Eli Lilly and Company 435,911 4.0%
74 Combivir GlaxoSmithKline 433,516 5.3%
75 Pulmicort Respules AstraZeneca Pharmaceuticals, LP 430,807 21.5%
76 Hyzaar Merck & Co., Inc. 427,072 11.4%
77 Mobic Abbott Laboratories 421,165 60.4%
78 Ortho Evra Ortho-McNeil-Janssen Pharmaceuticals, Inc. 411,189 23.2%
79 Procrit Centocor Ortho Biotech, Inc 406,212 -3.2%
80 Allegra-D Dr. Reddy's Laboratories Inc. 403,507 -8.1%
81 Cellcept Roche Pharmaceuticals 399,650 15.5%
82 Skelaxin Elan Corporation 399,381 8.6%
83 Trileptal Novartis Corporation 399,001 27.7%
84 Xalatan Pfizer Inc 390,196 7.5%
85 Omnicef Abbott Laboratories 381,124 26.8%
86 Prograf Astellas Pharma US 362,051 20.5%
87 Viread Gilead Sciences, Inc. 350,319 34.5%
88 Provigil Cephalon, Inc. (a wholly-owned subsidiary of Teva Pharmaceutical Industries Ltd) 348,785 36.4%
89 Elidel Novartis Corporation 347,733 43.8%
90 Geodon Oral Pfizer Inc 337,826 35.2%
91 Ditropan XL Janssen Pharmaceuticals, Inc 335,038 2.3%
92 Lovenox Sanofi (formerly Sanofi Aventis) 330,773 8.8%
93 Zithromax Pfizer Inc 330,200 28.6%
94 Avandamet GlaxoSmithKline 330,146 192.8%
95 Yasmin 28 Bayer Healthcare Pharmaceuticals 327,574 51.8%
96 Depakote ER Abbott Laboratories 326,183 35.1%
97 Avapro Bristol-Myers Squibb Company 323,367 12.3%
98 Asacol Procter & Gamble 322,219 7.4%
99 Ultracet Janssen Pharmaceuticals, Inc 321,984 16.4%
100 Lidoderm Endo Pharmaceuticals 313,786 69.0%
101 Diflucan Pfizer Inc 312,619 -27.9%
102 Nasacort AQ Sanofi (formerly Sanofi Aventis) 309,590 9.5%
103 Rhinocort Aqua AstraZeneca Pharmaceuticals, LP 307,406 6.0%
104 Sustiva Bristol-Myers Squibb Company 296,783 15.5%
105 Trizivir GlaxoSmithKline 291,605 -1.2%
106 Levoxyl King Pharmaceuticals, Inc. (now part of Pfizer - October 2010) 291,498 -17.3%
107 Zithromax Susp 289,444 -6.9%
108 Kaletra Abbott Laboratories 289,392 3.9%
109 Keppra UCB Inc. 288,777 42.1%
110 Humira Abbott Laboratories 286,283 109.6%
111 Niaspan Abbott Laboratories 285,880 49.6%
112 Ortho Tri-Cyclen Janssen Pharmaceuticals, Inc 283,274 -62.6%
113 Avonex Biogen Idec 280,874 -0.1%
114 Amaryl Sanofi (formerly Sanofi Aventis) 278,094 18.2%
115 Copaxone Sanofi (formerly Sanofi Aventis) 275,838 -0.6%
116 Prilosec AstraZeneca Pharmaceuticals, LP 266,809 -64.3%
117 Metformin HCl ER 265,898 >999
118 Actiq Abbott Laboratories 262,320 32.4%
119 Patanol Alcon Laboratories, Inc. 257,327 4.8%
120 Coumadin Tabs Bristol-Myers Squibb Company 253,341 -10.2%
121 Zelnorm Novartis Corporation 251,846 89.4%
122 Ortho Tri-Cyclen Lo Ortho-McNeil-Janssen Pharmaceuticals, Inc. 247,173 160.8%
123 Biaxin XL Abbott Laboratories 244,968 -16.2%
124 AndroGel Abbott Laboratories 242,917 10.7%
125 Arimidex AstraZeneca Pharmaceuticals, LP 240,802 48.4%
126 Glucovance Bristol-Myers Squibb Company 240,686 -44.5%
127 Cefzil Bristol-Myers Squibb Company 240,520 -22.8%
128 Xopenex Sepracor Inc. (renamed Sunovion Pharmaceuticals Inc) 240,430 14.9%
129 Avelox Bayer Healthcare Pharmaceuticals 235,322 4.6%
130 Augmentin XR Dr. Reddy's Laboratories Inc. 233,839 14.0%
131 Proscar Merck & Co., Inc. 233,194 8.2%
132 Endocet Endo Pharmaceuticals 231,148 90.8%
133 Reyataz Bristol-Myers Squibb Company 228,081 357.3%
134 Avalide Bristol-Myers Squibb Company 225,070 32.9%
135 Lescol XL Novartis Corporation 218,382 10.7%
136 Norvir Abbott Laboratories 211,971 440.6%
137 Aldara Medicis Pharmaceutical Corporation 210,160 23.3%
138 Gleevec Novartis Corporation 208,952 34.2%
139 Zyrtec Syrup 208,884 -1.7%
140 Budeprion SR Teva Pharmaceuticals 203,954 NA
141 Epivir GlaxoSmithKline 202,566 -1.1%
142 Miacalcin Nasal Novartis Corporation 201,855 0.1%
143 Augmentin ES-600 Dr. Reddy's Laboratories Inc. 201,822 -23.3%
144 Serevent Diskus GlaxoSmithKline 200,636 48.7%
145 Trinessa Watson Pharmaceuticals, Inc. (now Actavis, Inc) 195,038 >999
146 Pegasys Genentech, Inc (member of Roche group) 191,754 41.3%
147 Accutane Roche Pharmaceuticals 191,441 -29.7%
148 Alphagan P Allergan, Inc 189,749 -4.0%
149 Klor-Con Upsher-Smith Laboratories Inc. 189,304 -5.5%
150 BenzaClin Sanofi (formerly Sanofi Aventis) 189,081 6.8%
151 Humalog Mix 75/25 Pn 189,024 -11.6%
152 Biaxin Abbott Laboratories 187,485 -15.4%
153 Humulin N Eli Lilly and Company 185,325 -17.8%
154 Amnesteem Mylan Inc. 184,826 -3.6%
155 Inderal LA Wyeth 184,484 -1.2%
156 Prozac Eli Lilly and Company 181,717 -18.2%
157 Cipro Bayer Healthcare Pharmaceuticals 181,254 -73.1%
158 Benicar Daiichi Sankyo 177,847 91.6%
159 Cosopt Merck & Co., Inc. 176,797 10.5%
160 Famvir GlaxoSmithKline 175,962 3.2%
161 RenaGel Genzyme Corporation 175,737 19.9%
162 DDAVP Sanofi (formerly Sanofi Aventis) 175,548 9.4%
163 Cialis Eli Lilly and Company 174,849 >999
164 Paxil Apotex Corp 171,499 -87.3%
165 Casodex AstraZeneca Pharmaceuticals, LP 171,366 3.9%
166 Thalomid Celgene Corporation 169,566 31.7%
167 Arava Sanofi (formerly Sanofi Aventis) 168,839 14.0%
168 Zofran ODT GlaxoSmithKline 164,910 61.9%
169 Forteo Eli Lilly and Company 163,148 214.5%
170 Namenda Forest Pharmaceuticals, Inc 161,930 >999
171 Zyrtec-D Pfizer Inc 161,758 2.3%
172 Differin Galderma Laboratories 161,587 3.9%
173 Betaseron Bayer Healthcare Pharmaceuticals 159,381 2.1%
174 Neupogen Amgen Inc. 157,428 -16.1%
175 Zomig AstraZeneca Pharmaceuticals, LP 157,216 -9.2%
176 Temodar Merck & Co., Inc. 155,938 19.6%
177 Catapres-TTS Boehringer Ingelheim Pharmaceuticals, Inc 154,143 7.8%
178 Tobradex Alcon Laboratories, Inc. 153,757 -4.2%
179 Atacand AstraZeneca Pharmaceuticals, LP 153,224 -2.1%
180 Humulin 70/30 Eli Lilly and Company 152,321 -15.2%
181 Lumigan Allergan, Inc 148,024 18.8%
182 Mirapex Boehringer Ingelheim Pharmaceuticals, Inc 143,300 11.6%
183 Tussionex Sanofi (formerly Sanofi Aventis) 140,072 -5.3%
184 Xeloda Genentech, Inc (member of Roche group) 139,676 8.2%
185 Reminyl Johnson & Johnson 138,931 17.7%
186 Exelon Novartis Corporation 138,094 -4.5%
187 Prempro Pfizer Inc 137,847 -37.3%
188 DuoNeb Dey Pharma 134,801 51.3%
189 Rebif 134,198 23.2%
190 Dovonex Bristol-Myers Squibb Company 134,137 -1.6%
191 Imitrex Inj 133,684 -20.8%
192 Zonegran Eisai Corporation 133,600 39.5%
193 Pletal Pfizer Inc 132,987 -0.4%
194 Fuzeon Roche Pharmaceuticals 129,369 416.3%
195 Plendil AstraZeneca Pharmaceuticals, LP 129,306 -15.4%
196 Iressa AstraZeneca Pharmaceuticals, LP 128,419 146.4%
197 Aviane Teva Pharmaceuticals 127,726 3.9%
198 Viramune Boehringer Ingelheim Pharmaceuticals, Inc 127,683 5.3%
199 Tequin Bristol-Myers Squibb Company 127,612 -19.2%
200 Zerit Bristol-Myers Squibb Company 126,427 -22.1%
All Others 24,121,195 -6.8%

Source: Verispan, VONA

View data for: 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012

Hide
(web3)